BALPHARMA

BAL PHARMA

Small Cap BSE: 524824 NSE: BALPHARMA
₹97.00
-2.35 (-2.37%)
As on 13 August, 2022 | 05:02

Bal Pharma Share Price

Bal Pharma Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Bal Pharma Share Returns

  • Over 1 Month 4.98%
  • Over 3 Month -1.72%
  • Over 6 Month -17.23%
  • Over 1 Year -3.19%

Bal Pharma Key Statistics

P/E Ratio 33.7
PEG Ratio -1.3
Market Cap Cr 151
Price to Book Ratio 2.6
EPS 5.5
Dividend 1
Relative Strength Index 47.14
Money Flow Index 43.96
MACD Signal 0.59
Average True Range 3.57

Bal Pharma Investment Rating

  • Master Rating:
  • Bal Pharma has an operating revenue of Rs. 281.21 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 3% needs improvement, ROE of 9% is fair but needs improvement. The company has a reasonable debt to equity of 46%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 33 which is a POOR score indicating inconsistency in earnings, a RS Rating of 33 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 105 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Bal Pharma Financials
  • Indicator
  • Jun 2022
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 70
  • 74
  • 69
  • 67
  • 71
  • 70
  • Operating Expenses Qtr Cr
  • 64
  • 70
  • 63
  • 61
  • 64
  • 63
  • Operating Profit Qtr Cr
  • 5
  • 3
  • 6
  • 6
  • 7
  • 7
  • Depreciation Qtr Cr
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • Interest Qtr Cr
  • 2
  • 2
  • 2
  • 3
  • 3
  • 3
  • Tax Qtr Cr
  • 0
  • 0
  • 2
  • 0
  • 1
  • -2
  • Net Profit Qtr Cr
  • 1
  • 3
  • 1
  • 3
  • 2
  • 4

Bal Pharma Technicals

EMA & SMA

Current Price
97.05
-2.3 (-2.32%)
  • Bullish Moving Average
  • ___
  • 1
  • Bearish Moving Average
  • ___
  • 15
  • 20 Day
  • 98.14
  • 50 Day
  • 98.6
  • 100 Day
  • 101.09
  • 200 Day
  • 106.06
  • 20 Day
  • 98.76
  • 50 Day
  • 96.6
  • 100 Day
  • 102.89
  • 200 Day
  • 106.15

Bal Pharma Resistance and Support

PIVOT
₹99.47
Resistance
  • First Resistance
  • 99.89
  • Second Resistance
  • 100.42
  • Third Resistance
  • 100.84
Support
  • First Resistance
  • 98.94
  • Second Resistance
  • 98.52
  • Third Resistance
  • 97.99
  • RSI
  • 47.14
  • MFI
  • 43.96
  • MACD Single Line
  • 0.59
  • MACD
  • 0.42

Bal Pharma Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 25,477
  • 1,717,659
  • 67.42
  • Week
  • 21,669
  • 1,397,000
  • 64.47
  • 1 Month
  • 47,984
  • 2,102,661
  • 43.82
  • 6 Month
  • 65,466
  • 2,875,249
  • 43.92

Bal Pharma Result Highlights

Bal Pharma Synopsis

NSE-Medical-Diversified

Bal Pharma Ltd belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 249.31 Cr. and Equity Capital is Rs. 14.82 Cr. for the Year ended 31/03/2021. Bal Pharma Ltd. is a Public Limited Listed company incorporated on 19/05/1987 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1987PLC008368 and registration number is 008368.
  • Market Cap
  • 151
  • Sales
  • 279
  • Shares in Float
  • 0.75
  • No of funds
  • 1
  • Yield
  • 1.03
  • Book Value
  • 1.65
  • U/D Vol ratio
  • 1.8
  • LTDebt / Equity
  • 4
  • Alpha
  • -0.01
  • Beta
  • 1.1

Bal Pharma

  • Owner Name
  • Jun-22
  • Apr-22
  • Mar-22
  • Dec-21
  • Promoters
  • 52%
  • 52%
  • 49.57%
  • Foreign Portfolio Investors
  • 0.3%
  • 0.3%
  • 0.31%
  • Individual Investors
  • 31.45%
  • 31.3%
  • 32.88%
  • Others
  • 16.25%
  • 16.4%
  • 17.24%

Bal Pharma Management

  • Name
  • Designation
  • Mr. Shailesh D Siroya
  • Managing Director
  • Mr. Himesh Virupakshaya
  • Executive Director
  • Mr. Jatish Sheth
  • Non Executive Director
  • Dr. C V Srinivas
  • Independent Director
  • Mr. H S Venkatesh
  • Independent Director
  • Ms. Nicloa Neeladri
  • Independent Director

Bal Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Bal Pharma Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-08-11
  • Quarterly Results
  • 2022-05-30
  • Audited Results & Final Dividend
  • 2022-04-13
  • Preferential issue of shares
  • 2022-03-09
  • Scheme of Amalgamation
  • Inter alia consider approval of scheme of amalgamation between Bal Pharma Ltd and its wholly owned subsidiary i.e Golden Drugs Private Ltd. per share(10%)Dividend
  • 2022-02-10
  • Quarterly Results

Bal Pharma FAQs

What is Share Price of Bal Pharma ?

Bal Pharma share price is ₹97 As on 13 August, 2022 | 04:48

What is the Market Cap of Bal Pharma ?

The Market Cap of Bal Pharma is ₹151.1 Cr As on 13 August, 2022 | 04:48

What is the P/E ratio of Bal Pharma ?

The P/E ratio of Bal Pharma is 33.7 As on 13 August, 2022 | 04:48

What is the PB ratio of Bal Pharma ?

The PB ratio of Bal Pharma is 2.6 As on 13 August, 2022 | 04:48

Q1FY23